![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 39, 36116-36124, September 28, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
¶
From the Saccharomyces cerevisiae RNA
triphosphatase (Cet1) and RNA guanylyltransferase (Ceg1) interact
in vivo and in vitro to form a bifunctional
mRNA capping enzyme complex. Here we show that the
guanylyltransferase activity of Ceg1 is highly thermolabile in
vitro (98% loss of activity after treatment for 10 min at
35 °C) and that binding to recombinant Cet1 protein, or a synthetic peptide Cet1(232-265), protects Ceg1 from heat inactivation at physiological temperatures. Candida albicans
guanylyltransferase Cgt1 is also thermolabile and is stabilized by
binding to Cet1(232-265). In contrast, Schizosaccharomyces
pombe and mammalian guanylyltransferases are intrinsically
thermostable in vitro and they are unaffected by
Cet1(232-265). We show that the requirement for the Ceg1-binding domain of Cet1 for yeast cell growth can be circumvented by
overexpression in high gene dosage of a catalytically active mutant
lacking the Ceg1-binding site (Cet1(269-549)) provided that Ceg1 is
also overexpressed. However, such cells are unable to grow at 37 °C.
In contrast, cells overexpressing Cet1(269-549) in single copy grow at
all temperatures if they express either the S. pombe or
mammalian guanylyltransferase in lieu of Ceg1. Thus, the cell growth
phenotype correlates with the inherent thermal stability of the
guanylyltransferase. We propose that an essential function of the
Cet1-Ceg1 interaction is to stabilize Ceg1 guanylyltransferase activity
rather than to allosterically regulate its activity. We used
protein-affinity chromatography to identify the COOH-terminal segment
of Ceg1 (from amino acids 245-459) as an autonomous Cet1-binding
domain. Genetic experiments implicate two peptide segments,
287KPVSLYVW295 and
337WQNLKNLEQPLN348, as likely constituents of
the Cet1-binding site on Ceg1.
Molecular Biology Program, Sloan-Kettering
Institute, New York, New York 10021 and the § Department of
Microbiology and Immunology, Weill Medical College of Cornell
University, New York, New York 10021
This article has been cited by other articles:
![]() |
S. Hausmann, Y. Pei, and S. Shuman Homodimeric Quaternary Structure Is Required for the in Vivo Function and Thermal Stability of Saccharomyces cerevisiae and Schizosaccharomyces pombe RNA Triphosphatases J. Biol. Chem., August 15, 2003; 278(33): 30487 - 30496. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Srinivasan, F. Piano, and A. J. Shatkin mRNA Capping Enzyme Requirement for Caenorhabditis elegans Viability J. Biol. Chem., April 11, 2003; 278(16): 14168 - 14173. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takagi, A. K. Walker, C. Sawa, F. Diehn, Y. Takase, T. K. Blackwell, and S. Buratowski The Caenorhabditis elegans mRNA 5'-Capping Enzyme. IN VITRO AND IN VIVO CHARACTERIZATION J. Biol. Chem., April 11, 2003; 278(16): 14174 - 14184. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takagi, E.-J. Cho, R. T. K. Janoo, V. Polodny, Y. Takase, M.-C. Keogh, S.-A. Woo, L. D. Fresco-Cohen, C. S. Hoffman, and S. Buratowski Divergent Subunit Interactions among Fungal mRNA 5'-Capping Machineries Eukaryot. Cell, June 1, 2002; 1(3): 448 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Ho and S. Shuman Trypanosoma brucei RNA Triphosphatase. ANTIPROTOZOAL DRUG TARGET AND GUIDE TO EUKARYOTIC PHYLOGENY J. Biol. Chem., November 30, 2001; 276(49): 46182 - 46186. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hausmann, C. P. Vivares, and S. Shuman Characterization of the mRNA Capping Apparatus of the Microsporidian Parasite Encephalitozoon cuniculi J. Biol. Chem., January 4, 2002; 277(1): 96 - 103. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |